Evidence of impaired glucose tolerance and insulin resistance in patients with Alzheimer's disease

Current Directions in Psychological Science

Volumn 10, Issue 3, 2001, Pages 102-105

  Nolan, Jennifer H ^a,b   Wright, Charles E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOYOLA MARYMOUNT UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Blood sugar; Cognition; Diabetes; Insulin resistance

Indexed keywords

EID: 0035533678     PISSN: 09637214     EISSN: None     Source Type: Journal    
DOI: 10.1111/1467-8721.00126     Document Type: Article

References (10)

1. American Diabetes Association. (2000). Diabetes facts and figures [On-line]. Available: http:/ / www.diabetes.org/ada/facts.asp
2. Craft, S., Dagogo-Jack, S., Wiethop, B., Murphy, C., Nevins, R., Fleischman, S., Rice, V., Newcomer, J., & Cryer, P. (1993). Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: A longitudinal study. Behavioral Neuroscience, 107, 926-940.
3. Craft, S., Peskind, E., Schwartz, M., Schellenberg, G., Raskind, M., & Porte, D., Jr. (1998). Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E genotype. Neurology, 50, 164-168.
4. Devaskar, S. (1991). A review of insulin/insulin-like peptide in the central nervous system. In M. Raizada & D. LeRoith (Eds.), Molecular biology and physiology of insulin and insulin-like growth factors (pp. 385-396). New York: Plenum Press.
5. Doré, S., Kar, S., & Quiron, R. (1997). Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity. Neurobiology, 94, 4772-4777.
6. Fajans, S. (1996). Definition and classification of diabetes including maturity-onset diabetes of the young. In D. LeRoith, S. Taylor, & J. Olefsky (Eds.), Diabetes mellitus: A fundamental and clinical text (pp. 251-260). Philadelphia: Lippincott-Raven.
7. Flier, J. (1993). An overview of insulin resistance. In D.E. Moller (Ed.), Insulin resistance (pp. 1-8). New York: John Wiley & Sons.
8. Hoyer, S. (1994). Neurodegeneration, Alzheimer's disease, and beta-amyloid toxicity. Life Sciences, 55, 1977-1983.
9. Kurochkin, I., & Goto, S. (1994). Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Letters, 345, 33-37.
10. Nielson, K., Nolan, J., Berchtold, N., Sandman, C., Mulnard, R., & Cotman, C. (1996). Apolipoprotein-E genotyping of diabetic dementia patients: Is diabetes rare in Alzheimer disease? Journal of the American Geriatrics Society, 44, 897-904.